Therapeutic Research Center (TRC) Acquires CriticalPoint and Clinical IQ
April 8, 2020
Therapeutic Research Center (TRC), a portfolio company of Levine Leichtman Capital Partners, has acquired CriticalPoint, LLC and Clinical IQ, LLC to expand its sterile compounding training, consulting and compliance capabilities. The deal augments TRC's education platform and strengthens its domain expertise in compounding, aseptic processing and USP compliance.
- Buyers
- Therapeutic Research Center, LLC (TRC), Levine Leichtman Capital Partners
- Targets
- CriticalPoint, LLC, Clinical IQ, LLC
- Platforms
- Therapeutic Research Center, LLC (TRC)
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
TRC Healthcare Acquires CriticalPoint and Kastango Consulting Group
April 7, 2020
Healthcare Services
TRC Healthcare (Therapeutic Research Center) acquired CriticalPoint, LLC and Kastango Consulting Group (formerly Clinical IQ, LLC) to expand its sterile and non-sterile compounding training, eLearning, and consulting offerings. The deal brings CriticalPoint's eLearning, live training, SOPs and peer networks together with Kastango's customized consulting services to strengthen TRC's medication safety and clinical education portfolio.
-
Therapeutic Research Center (LLCP Portfolio Company) Acquires NetCE
March 8, 2021
Healthcare Services
Therapeutic Research Center (TRC), a portfolio company of Levine Leichtman Capital Partners (LLCP), has acquired CE Resources, Inc., d/b/a NetCE, a Roseville, California–based continuing education platform for healthcare professionals. The acquisition expands TRC's clinician education platform and content library to reach a broader set of nurses, physicians and mental health professionals.
-
Colibri Group (Gridiron-backed) Acquires TRC Healthcare from Levine Leichtman
November 20, 2023
Healthcare Services
Colibri Group, a Gridiron Capital-backed professional education platform, has acquired TRC Healthcare (Therapeutic Research Center) from Levine Leichtman Capital Partners. TRC is a market-leading provider of evidence-based continuing education, pharmacy products and clinical simulation serving over 1 million clinicians and 3,500+ hospitals; financial terms were not disclosed.
-
TRC Healthcare Acquires QURE Healthcare
March 15, 2022
Healthcare Services
TRC Healthcare, a Denver-based provider of continuing education for healthcare professionals, has acquired QURE Healthcare to scale QURE's Clinical Performance and Value (CPV) patient simulation software and strengthen TRC's evidence-based education offerings. QURE founder Dr. John Peabody will continue as QURE's president and will also serve as Chief Medical Officer at TRC, as the acquisition aims to reduce unwarranted variation in care and improve patient outcomes.
-
Trinity Hunt Partners Makes Majority Investment in Centricity Research
May 31, 2023
Healthcare Services
Trinity Hunt Partners has made a majority investment in Centricity Research, a North American integrated clinical research organization that conducts Phase I–IV trials across over 40 therapeutic areas. Trinity Hunt said it will partner with Centricity’s management to invest in organic growth and acquire complementary clinical research site businesses to expand capabilities and therapeutic coverage across the U.S. and Canada.
-
Great Point Partners-backed VitaLink Research Acquires Comprehensive Clinical Trials
August 12, 2019
Healthcare Services
VitaLink Research, a clinical research site business backed by Great Point Partners, has acquired West Palm Beach-based Comprehensive Clinical Trials (CCT). The acquisition expands VitaLink's women's health clinical trial capabilities and increases patient access across the Southeast; Dr. Ronald Ackerman will continue to lead the CCT business.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.